Clinical Management of Dystonia in Childhood.

Abstract

Dystonia is one of the most frequent movement disorders in childhood. It can impede normal motor development and cause significant motor disability. The diagnostic evaluation of childhood dystonia is challenging due to the phenotypic variability and heterogeneous etiologies. Evidence to guide the diagnostic evaluation and treatment is limited. Assessment is primarily directed by clinical history and distinctive examination findings. Neuroimaging is typically necessary to evaluate for acquired or complex inherited dystonias. A trial of levodopa can be both diagnostic and therapeutic in children with dopa-responsive dystonia. However, for the majority of children with early-onset dystonia, treatment is symptomatic with varying efficacy. There is a paucity of therapeutic trials for childhood dystonia and most treatment recommendations are consensus or expert opinion driven. This review summarizes the available evidence and guidelines on the diagnostic evaluation and pharmacological treatment of childhood-onset dystonia and provides practical frameworks to approach both issues based on best evidence.

• Authors: Quyen N Luc, Jyes Querubin
• Journal: Paediatric drugs (Paediatr Drugs) Vol. 19 Issue 5 Pg. 447-461 (Oct 2017) ISSN: 1179-2019 [Electronic] Switzerland
• PMID: 28620849 (Publication Type: Journal Article, Review)

Topics

• Dystonia (classification, diagnosis, drug therapy, etiology)
• Dystonic Disorders (diagnosis, drug therapy, etiology)
• Humans